Publicaciones (24) Publicaciones de SARA CUESTA SANCHO

2024

  1. Sprouty1 is a broad mediator of cellular senescence

    Cell Death and Disease, Vol. 15, Núm. 4

2023

  1. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

    Frontiers in Microbiology, Vol. 14

2022

  1. A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

  2. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

    World Journal of Hepatology, Vol. 14, Núm. 1, pp. 62-79

  3. Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

    Biomedicines, Vol. 10, Núm. 10

2021

  1. Neutrophil Expression of T and B Immunomodulatory Molecules in HIV Infection

    Frontiers in Immunology, Vol. 12

2019

  1. Sprouty1 controls genitourinary development via its N-terminal tyrosine

    Journal of the American Society of Nephrology, Vol. 30, Núm. 8, pp. 1398-1411

2017

  1. Protective effect of resveratrol against inflammation, oxidative stress and apoptosis in pancreas of aged SAMP8 mice

    Experimental Gerontology, Vol. 90, pp. 61-70

2016

  1. Fibersol-2 induces apoptosis of Apc-deficient colorectal Cancer (SW480) cells and decreases polyp formation in Apc MIN mice

    Cancer Biology and Therapy, Vol. 17, Núm. 6, pp. 657-663

  2. Influence of aging and growth hormone on different members of the NFkB family and IkB expression in the heart from a murine model of senescence-accelerated aging

    Experimental Gerontology, Vol. 73, pp. 114-120

2015

  1. Tumor suppression by resistant maltodextrin, Fibersol-2

    Cancer Biology and Therapy, Vol. 16, Núm. 3, pp. 460-465

2014

  1. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: Improvement of protein balance and of antioxidant defenses

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 69, Núm. 10, pp. 1186-1198

2013

  1. Beneficial effect of melatonin treatment on agerelated insulin resistance and on the development of type 2 diabetes

    Hormone Molecular Biology and Clinical Investigation, Vol. 16, Núm. 2, pp. 47-54

  2. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8)

    Age, Vol. 35, Núm. 3, pp. 659-671

  3. Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis

    European Journal of Pharmacology, Vol. 701, Núm. 1-3, pp. 185-193

2012

  1. Age-related differences in hepatic ischemia/reperfusion: Gene activation, liver injury, and protective effect of melatonin

    Journal of Surgical Research, Vol. 178, Núm. 2, pp. 922-934

  2. Effect of chronic melatonin administration on several physiological parameters from old Wistar rats and Samp8 mice

    Current Aging Science, Vol. 5, Núm. 3, pp. 242-253

2011

  1. Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model

    Mechanisms of Ageing and Development, Vol. 132, Núm. 11-12, pp. 573-582

  2. Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 66 A, Núm. 8, pp. 823-834

  3. Effect of growth hormone and melatonin on the brain: From molecular mechanisms to structural changes

    Hormone Molecular Biology and Clinical Investigation, Vol. 7, Núm. 2, pp. 337-350